Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Myseum (MYSE) Shares Outstanding (Weighted Average) (2021 - 2025)

Historic Shares Outstanding (Weighted Average) for Myseum (MYSE) over the last 5 years, with Q3 2025 value amounting to $4.2 million.

  • Myseum's Shares Outstanding (Weighted Average) rose 4029.32% to $4.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.2 million, marking a year-over-year increase of 4029.32%. This contributed to the annual value of $3.0 million for FY2024, which is 4585.65% up from last year.
  • Per Myseum's latest filing, its Shares Outstanding (Weighted Average) stood at $4.2 million for Q3 2025, which was up 4029.32% from $4.2 million recorded in Q2 2025.
  • Myseum's 5-year Shares Outstanding (Weighted Average) high stood at $19.6 million for Q2 2022, and its period low was $2.0 million during Q4 2022.
  • Its 5-year average for Shares Outstanding (Weighted Average) is $7.0 million, with a median of $3.0 million in 2024.
  • As far as peak fluctuations go, Myseum's Shares Outstanding (Weighted Average) surged by 5117.53% in 2022, and later plummeted by 8948.47% in 2023.
  • Myseum's Shares Outstanding (Weighted Average) (Quarter) stood at $15.3 million in 2021, then tumbled by 86.89% to $2.0 million in 2022, then rose by 0.9% to $2.0 million in 2023, then surged by 45.86% to $3.0 million in 2024, then skyrocketed by 42.69% to $4.2 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $4.2 million for Q3 2025, versus $4.2 million for Q2 2025 and $4.1 million for Q1 2025.